Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO™

Back to Jobs

SAN DIEGO , May 20, 2016 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that the Centers for Medicare and Medicaid Services (CMS) has

Apply Now